InvestorLens

DXCM — DEXCOM INC

Health Care

Sign in to save6 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying DXCM?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
95
Institutional Conviction
Net accumulation · 5 buying vs 0 selling last quarter
73
Macro Tailwind
Macro conditions are mixed for this sector
53
Congressional Activity
0 congressional purchases, 2 sales disclosed in the last 6 months
Why? — Evidence & Confidence ▾

Of 5 tracked investors who changed their DXCM position last quarter, 5 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 53/100 in a Overheat regime). 0 congressional purchases, 2 sales disclosed in the last 6 months.

Supporting evidence
  • +5 tracked investors added or increased positions last quarter (Steve Cohen, Paul Tudor Jones, George Soros, …)
  • +6 tracked investors reported holding DXCM at their latest filing
Contradicting evidence — always shown
  • −Congressional disclosures lean toward selling (2 sales vs 0 purchases, 6 months)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.

About DEXCOM INC (DXCM)

DEXCOM INC (DXCM) appears in the most recent 13F filings of 6 tracked institutional investors. DEXCOM INC is classified in the Health Care sector. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $623M. Across recent filings, tracked investors recorded 10 new positions, 13 increased, 10 reduced, and 4 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in DXCM

62
/100
Institutional Accumulation
Added / Increased23
Reduced10
Exited4
BearishBullish
Crowded Trade Score™

How many top investors track DXCM

40
/100
Moderate Interest
6investors

Several tracked investors have exposure.

UndiscoveredCrowded
151015+

DXCM Ownership Composition

How DEXCOM INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Multi-Strategy / Quant
51% of tracked value
Institutions
6
tracked investors
Total Reported
$430M
combined 13F value
Types3
  • Multi-Strategy / Quant50.6%
  • Macro36.1%
  • Value & Distressed13.3%
Multi-Strategy / Quant(2)
50.6%
Macro(3)
36.1%
Value & Distressed(1)
13.3%

Tracked investors currently reporting DXCM

1 tracked investor has since exited this position — listed separately below.

  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    2.8M
    Value
    $185.9M
    % Portfolio
    0.02%
  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    471.6K
    Value
    $31.8M
    % Portfolio
    0.01%
  • Paul Tudor JonesJun 30, 2026
    Tudor Investment Corp
    Shares
    69.2M
    Value
    $64.7M
    % Portfolio
    0.09%
  • George SorosJun 30, 2026
    Soros Fund Management
    Shares
    68M
    Value
    $63.5M
    % Portfolio
    0.78%
  • Howard MarksJun 30, 2026
    Oaktree Capital Management
    Shares
    61.1M
    Value
    $57.1M
    % Portfolio
    0.79%
  • Ray DalioJun 30, 2026
    Bridgewater Associates
    Shares
    400.9K
    Value
    $27M
    % Portfolio
    0.11%

Previously held DXCM

These investors reported DXCM in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Steve CohenPoint72 Asset Management335.9K$21.1MMar 31, 2026

Recent activity

Frequently asked questions

How many institutional investors hold DXCM?
6 tracked institutional investors disclosed a position in DXCM (DEXCOM INC) in their most recent 13F filing.
Who is the largest institutional holder of DXCM?
Ken Griffin, Citadel Advisors, holds the largest disclosed position in DXCM, valued at $623M.
Did institutional ownership of DXCM increase or decrease?
Across recent 13F filings, tracked investors recorded 10 new positions, 13 increased, 10 reduced, and 4 fully exited DXCM.
What sector is DXCM in?
DEXCOM INC is classified in the Health Care GICS sector.
Where does this DXCM ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.
DXCM (DEXCOM INC) — Institutional Holders & 13F History — InvestorLens